Suppr超能文献

[肝门部胆管癌切除而非胆道姑息性引流]

[Resection of juxtahilar bile duct carcinoma instead of palliative drainage of the biliary tract].

作者信息

Pichlmayr R, Lehr L, Ziegler H

出版信息

Langenbecks Arch Chir. 1983;359(4):275-88. doi: 10.1007/BF01257314.

Abstract

Instead of the widely recommended approach of treating hilar carcinoma of the bile ducts by simple palliative biliary drainage, step by step a policy of primarily aiming at resection for cure has been adopted. So far in 11 out of 22 patients excision of the tumor was possible by resection of the hepatic duct confluence; in 4 cases a left hemihepatectomy had to be added because of carcinomatous infiltration of the left liver lobe or the left hepatic artery. The multiple bile duct openings remaining after resection of such tumors were reconstructed to one or two orifices and a bi- or unilateral Roux-en-Y cholangiojejunal anastomosis performed. In further 3 cases orthotopic liver transplantation was necessary to remove all visibly infiltrated tissue. In the remaining 8 patients because of documented extrahepatic carcinomatous spread palliative biliary drainage by a percutaneous U-tube or an endoprothesis was indeed considered the only reasonable measure. Despite the relatively high resectional rate of 60% and the extensive operations performed early mortality was confined to one patient who succumbed to septic endocarditis 6 weeks after the operation. At present the longest postoperative interval without recurrence amounts to 3 1/2 years. Nine patients free of recurrent disease are in perfect health; in 3 patients in whom a recurrence was observed after 1/2, 1 1/2 and 2 years meanwhile palliation was perfect. In contrast all patients with unresected tumors but carrying draining stents suffered from cholangitis and after 1 1/2 years all but one had died. In conclusion resectional therapy for hilar carcinoma seems possible with acceptable risk. Since only resection can provide potential cure and also palliation was better than that achieved by draining tubes a more aggressive attitude to the treatment of these lesions is advocated from our experience.

摘要

对于肝门部胆管癌,已逐步采用主要以根治性切除为目标的策略,而不再是广泛推荐的单纯姑息性胆管引流方法。到目前为止,22例患者中有11例通过肝管汇合部切除术成功切除肿瘤;4例因左肝叶或左肝动脉受癌浸润而不得不加做左半肝切除术。此类肿瘤切除后剩余的多个胆管开口被重建为一两个开口,并进行了双侧或单侧的Roux-en-Y胆管空肠吻合术。另有3例需要进行原位肝移植以切除所有可见的浸润组织。其余8例患者由于有肝外癌转移的记录,经皮置入U形管或内置假体进行姑息性胆管引流确实被认为是唯一合理的措施。尽管切除率相对较高,达60%,且手术范围广泛,但早期死亡率仅1例,该患者术后6周死于感染性心内膜炎。目前术后最长无复发间隔时间达3年半。9例无复发疾病的患者健康状况良好;3例分别在术后半年、1年半和2年出现复发的患者,同时期姑息治疗效果良好。相比之下,所有未切除肿瘤但带有引流支架的患者均患有胆管炎,1年半后除1例患者外其余均死亡。总之,肝门部胆管癌的切除治疗似乎风险可接受。由于只有切除才能提供潜在的治愈机会,而且姑息治疗效果也优于引流管治疗,根据我们的经验,主张对这些病变采取更积极的治疗态度。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验